MX2017016401A - Composiciones inmunogenas. - Google Patents
Composiciones inmunogenas.Info
- Publication number
- MX2017016401A MX2017016401A MX2017016401A MX2017016401A MX2017016401A MX 2017016401 A MX2017016401 A MX 2017016401A MX 2017016401 A MX2017016401 A MX 2017016401A MX 2017016401 A MX2017016401 A MX 2017016401A MX 2017016401 A MX2017016401 A MX 2017016401A
- Authority
- MX
- Mexico
- Prior art keywords
- immunogenic compositions
- compositions
- protection against
- bacterial infection
- relates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0283—Shigella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
La presente invención se refiere a composiciones inmunógenas, en particular a composiciones de vacuna, para su uso para proporcionar protección frente a enfermedades provocadas por infección bacteriana por cepas de Shigella.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15020097 | 2015-06-16 | ||
PCT/EP2016/063776 WO2016202872A1 (en) | 2015-06-16 | 2016-06-15 | Immunogenic compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2017016401A true MX2017016401A (es) | 2018-03-02 |
Family
ID=53442444
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2017016401A MX2017016401A (es) | 2015-06-16 | 2016-06-15 | Composiciones inmunogenas. |
Country Status (10)
Country | Link |
---|---|
US (2) | US20180169206A1 (es) |
EP (2) | EP3310381B1 (es) |
JP (2) | JP6930927B2 (es) |
CN (2) | CN107921116A (es) |
AR (1) | AR105010A1 (es) |
BE (1) | BE1024284B1 (es) |
CA (1) | CA2989242A1 (es) |
ES (1) | ES2952422T3 (es) |
MX (1) | MX2017016401A (es) |
WO (1) | WO2016202872A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2989242A1 (en) * | 2015-06-16 | 2016-12-22 | Glaxosmithkline Biologicals Sa | Immunogenic compositions |
GB201712824D0 (en) * | 2017-08-10 | 2017-09-27 | Glaxosmithkline Biologicals Sa | Multi-functionalized nOMV Conjugates |
JP2021519789A (ja) | 2018-04-03 | 2021-08-12 | ユニバーシティ オブ メリーランド,ボルチモア | 増強された多価赤痢菌−毒素原性大腸菌ワクチン |
TWI722535B (zh) * | 2018-08-21 | 2021-03-21 | 美商美國禮來大藥廠 | 測定蛋白質或肽濃度的方法及其用途 |
EP3808372A1 (en) * | 2019-10-17 | 2021-04-21 | GlaxoSmithKline Biologicals S.A. | Novel vaccine compositions |
GB202112149D0 (en) * | 2021-08-24 | 2021-10-06 | Glaxosmithkline Biologicals Sa | Shigellla vaccine |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5897475A (en) | 1994-10-05 | 1999-04-27 | Antex Biologics, Inc. | Vaccines comprising enhanced antigenic helicobacter spp. |
GB0917003D0 (en) | 2009-09-28 | 2009-11-11 | Novartis Vaccines Inst For Global Health Srl | Purification of bacterial vesicles |
GB0917002D0 (en) | 2009-09-28 | 2009-11-11 | Novartis Vaccines Inst For Global Health Srl | Improved shigella blebs |
GB201017519D0 (en) * | 2010-10-15 | 2010-12-01 | Novartis Vaccines Inst For Global Health S R L | Vaccines |
WO2014153087A1 (en) * | 2013-03-14 | 2014-09-25 | President And Fellows Of Harvard College | Nanoparticle-based compositions |
IN2013DE01652A (es) * | 2013-05-31 | 2015-06-26 | Indian Council Medical Res | |
CN103966308B (zh) | 2013-12-31 | 2016-04-06 | 中国疾病预防控制中心传染病预防控制所 | 福氏志贺菌o-抗原3/4-o-乙酰化修饰检测试剂及其应用 |
CN103933559B (zh) * | 2014-04-29 | 2016-08-17 | 北京智飞绿竹生物制药有限公司 | 志贺氏菌多价结合疫苗 |
US10500263B2 (en) * | 2014-07-25 | 2019-12-10 | Biosynth S.R.L. | Glycoconjugate vaccines comprising basic units of a molecular construct expressing built-in multiple epitopes for the formulation of a broad-spectrum vaccine against infections due to enteropathogenic bacteria |
CA2989242A1 (en) * | 2015-06-16 | 2016-12-22 | Glaxosmithkline Biologicals Sa | Immunogenic compositions |
ES2847947T3 (es) | 2016-11-25 | 2021-08-04 | Glaxosmithkline Biologicals Sa | Conjugados de VMEn-antígeno nativas y uso de los mismos |
-
2016
- 2016-06-15 CA CA2989242A patent/CA2989242A1/en active Pending
- 2016-06-15 MX MX2017016401A patent/MX2017016401A/es unknown
- 2016-06-15 JP JP2017564856A patent/JP6930927B2/ja active Active
- 2016-06-15 US US15/736,691 patent/US20180169206A1/en not_active Abandoned
- 2016-06-15 BE BE2016/5444A patent/BE1024284B1/fr active IP Right Grant
- 2016-06-15 ES ES16732999T patent/ES2952422T3/es active Active
- 2016-06-15 CN CN201680047677.8A patent/CN107921116A/zh active Pending
- 2016-06-15 EP EP16732999.4A patent/EP3310381B1/en active Active
- 2016-06-15 CN CN202210442482.0A patent/CN114796472A/zh active Pending
- 2016-06-15 WO PCT/EP2016/063776 patent/WO2016202872A1/en active Application Filing
- 2016-06-15 AR ARP160101784A patent/AR105010A1/es unknown
- 2016-06-15 EP EP23170627.6A patent/EP4241851A3/en active Pending
-
2020
- 2020-08-05 US US16/985,979 patent/US11986518B2/en active Active
-
2021
- 2021-06-16 JP JP2021099800A patent/JP2021167317A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2016202872A1 (en) | 2016-12-22 |
US11986518B2 (en) | 2024-05-21 |
CN114796472A (zh) | 2022-07-29 |
EP3310381A1 (en) | 2018-04-25 |
JP6930927B2 (ja) | 2021-09-01 |
CN107921116A (zh) | 2018-04-17 |
EP4241851A3 (en) | 2023-12-06 |
BE1024284A1 (fr) | 2018-01-12 |
AR105010A1 (es) | 2017-08-30 |
US20180169206A1 (en) | 2018-06-21 |
JP2021167317A (ja) | 2021-10-21 |
US20200384096A1 (en) | 2020-12-10 |
BE1024284B1 (fr) | 2018-01-15 |
EP3310381B1 (en) | 2023-06-07 |
EP4241851A2 (en) | 2023-09-13 |
CA2989242A1 (en) | 2016-12-22 |
ES2952422T3 (es) | 2023-10-31 |
JP2018517729A (ja) | 2018-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL279978B (en) | Preparations containing bacterial strains | |
IL276288A (en) | Preparations containing bacterial strains | |
MA40754A (fr) | Compositions comprenant des souches bactériennes | |
MA45287A (fr) | Compositions comprenant des souches bactériennes | |
MA52860A (fr) | Compositions comprenant des souches bactériennes | |
MA51639A (fr) | Compositions comprenant des souches bactériennes | |
MA51455A (fr) | Compositions comprenant des souches bactériennes | |
MA49425A (fr) | Compositions comprenant des souches bactériennes | |
HUE046221T2 (hu) | Bakteriális törzseket tartalmazó készítmények | |
PT3650033T (pt) | Composições compreendendo estirpes bacterianas | |
GB201520497D0 (en) | Compositions comprising bacterial strains | |
MX2017016401A (es) | Composiciones inmunogenas. | |
MA48941A (fr) | Compositions comprenant des souches bactériennes | |
MA49982A (fr) | Compositions comprenant des souches bactériennes | |
GB201616022D0 (en) | Compositions comprising bacterial strains | |
GB201616018D0 (en) | Compositions comprising bacterial strains | |
GB201616016D0 (en) | Compositions comprising bacterial strains | |
GB201604920D0 (en) | Compositions comprising bacterial strains | |
GB201604924D0 (en) | Compositions comprising bacterial strains | |
GB201603786D0 (en) | Compositions comprising bacterial strains | |
GB201603817D0 (en) | Compositions comprising bacterial strains | |
GB201510466D0 (en) | Compositions comprising bacterial strains | |
GB201510467D0 (en) | Compositions comprising bacterial strains | |
GB201510468D0 (en) | Compositions comprising bacterial strains | |
GB201510470D0 (en) | Compositions comprising bacterial strains |